The Role of Perivascular Adipose Tissue in the Pathogenesis of Endothelial Dysfunction in Cardiovascular Diseases and Type 2 Diabetes Mellitus

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2023 Nov 25

PMID 38002006

Authors

Alessia Valentini

Carmine Cardillo

David Della Morte

Manfredi Tesauro

Affiliations

Soon will be listed here.

Abstract

Cardiovascular diseases (CVDs) and type 2 diabetes mellitus (T2DM) are two of the four major chronic non-communicable diseases (NCDs) representing the leading cause of death worldwide. Several studies demonstrate that endothelial dysfunction (ED) plays a central role in the pathogenesis of these chronic diseases. Although it is well known that systemic chronic inflammation and oxidative stress are primarily involved in the development of ED, recent studies have shown that perivascular adipose tissue (PVAT) is implicated in its pathogenesis, also contributing to the progression of atherosclerosis and to insulin resistance (IR). In this review, we describe the relationship between PVAT and ED, and we also analyse the role of PVAT in the pathogenesis of CVDs and T2DM, further assessing its potential therapeutic target with the aim of restoring normal ED and reducing global cardiovascular risk.

Citing Articles

Visceral Adipose Tissue Inflammation and Vascular Complications in a Rat Model with Severe Dyslipidemia: Sex Differences and PAI-1 Tissue Involvement.

Markova I, Huttl M, Gayova N, Miklankova D, Cerna K, Kavanova M Biomolecules. 2025; 15(1).

PMID: 39858414 PMC: 11763299. DOI: 10.3390/biom15010019.

Vascular Function in Chronic Non-Communicable Diseases 2.0.

Noce A, Tesauro M Biomedicines. 2025; 12(12.

PMID: 39767668 PMC: 11673951. DOI: 10.3390/biomedicines12122761.

Current Understanding of Cardiovascular Calcification in Patients with Chronic Kidney Disease.

Chen S, Tang R, Liu B Int J Mol Sci. 2024; 25(18).

PMID: 39337709 PMC: 11432307. DOI: 10.3390/ijms251810225.

Ghrelin Expression in Atherosclerotic Plaques and Perivascular Adipose Tissue: Implications for Vascular Inflammation in Peripheral Artery Disease.

Peiu S, Iosep D, Danciu M, Scripcaru V, Ianole V, Mocanu V J Clin Med. 2024; 13(13).

PMID: 38999303 PMC: 11242600. DOI: 10.3390/jcm13133737.

References

Piepoli M, Hoes A, Agewall S, Albus C, Brotons C, Catapano A . 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by.... Eur Heart J. 2016; 37(29):2315-2381. PMC: 4986030. DOI: 10.1093/eurheartj/ehw106. View

Qi X, Qu S, Xiong W, Rom O, Chang L, Jiang Z . Perivascular adipose tissue (PVAT) in atherosclerosis: a double-edged sword. Cardiovasc Diabetol. 2018; 17(1):134. PMC: 6180425. DOI: 10.1186/s12933-018-0777-x. View

Menezes da Costa R, Neves K, Mestriner F, Louzada-Junior P, Bruder-Nascimento T, Tostes R . TNF-α induces vascular insulin resistance via positive modulation of PTEN and decreased Akt/eNOS/NO signaling in high fat diet-fed mice. Cardiovasc Diabetol. 2016; 15(1):119. PMC: 5000486. DOI: 10.1186/s12933-016-0443-0. View

. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2021; 45(Suppl 1):S144-S174. DOI: 10.2337/dc22-S010. View

Houben A, Eringa E, Jonk A, Serne E, Smulders Y, Stehouwer C . Perivascular Fat and the Microcirculation: Relevance to Insulin Resistance, Diabetes, and Cardiovascular Disease. Curr Cardiovasc Risk Rep. 2012; 6(1):80-90. PMC: 3251783. DOI: 10.1007/s12170-011-0214-0. View

Vanhoutte P, Shimokawa H, Feletou M, Tang E . Endothelial dysfunction and vascular disease - a 30th anniversary update. Acta Physiol (Oxf). 2015; 219(1):22-96. DOI: 10.1111/apha.12646. View

Ma Y, Li L, Shao Y, Bai X, Bai T, Huang X . Methotrexate improves perivascular adipose tissue/endothelial dysfunction via activation of AMPK/eNOS pathway. Mol Med Rep. 2017; 15(4):2353-2359. DOI: 10.3892/mmr.2017.6225. View

Kalle Kwaifa I, Bahari H, Yong Y, Md Noor S . Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications. Biomolecules. 2020; 10(2). PMC: 7072669. DOI: 10.3390/biom10020291. View

Xia N, Li H . The role of perivascular adipose tissue in obesity-induced vascular dysfunction. Br J Pharmacol. 2016; 174(20):3425-3442. PMC: 5610151. DOI: 10.1111/bph.13650. View

10.

Szasz T, Bomfim G, Webb R . The influence of perivascular adipose tissue on vascular homeostasis. Vasc Health Risk Manag. 2013; 9:105-16. PMC: 3616689. DOI: 10.2147/VHRM.S33760. View

11.

Xu S, Ilyas I, Little P, Li H, Kamato D, Zheng X . Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacol Rev. 2021; 73(3):924-967. DOI: 10.1124/pharmrev.120.000096. View

12.

Man A, Zhou Y, Xia N, Li H . Perivascular Adipose Tissue as a Target for Antioxidant Therapy for Cardiovascular Complications. Antioxidants (Basel). 2020; 9(7). PMC: 7402161. DOI: 10.3390/antiox9070574. View

13.

Ruze R, Liu T, Zou X, Song J, Chen Y, Xu R . Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments. Front Endocrinol (Lausanne). 2023; 14:1161521. PMC: 10161731. DOI: 10.3389/fendo.2023.1161521. View

14.

Han F, Hou N, Liu Y, Huang N, Pan R, Zhang X . Liraglutide improves vascular dysfunction by regulating a cAMP-independent PKA-AMPK pathway in perivascular adipose tissue in obese mice. Biomed Pharmacother. 2019; 120:109537. DOI: 10.1016/j.biopha.2019.109537. View

15.

Antonopoulos A, Margaritis M, Lee R, Channon K, Antoniades C . Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr Pharm Des. 2012; 18(11):1519-30. PMC: 3394171. DOI: 10.2174/138161212799504803. View

16.

Siegel-Axel D, Haring H . Perivascular adipose tissue: An unique fat compartment relevant for the cardiometabolic syndrome. Rev Endocr Metab Disord. 2016; 17(1):51-60. DOI: 10.1007/s11154-016-9346-3. View

17.

Williams I, Wasserman D . Capillary Endothelial Insulin Transport: The Rate-limiting Step for Insulin-stimulated Glucose Uptake. Endocrinology. 2021; 163(2). PMC: 8758342. DOI: 10.1210/endocr/bqab252. View

18.

Zhao L, Chai W, Fu Z, Dong Z, Aylor K, Barrett E . Globular adiponectin enhances muscle insulin action via microvascular recruitment and increased insulin delivery. Circ Res. 2013; 112(9):1263-71. PMC: 3971643. DOI: 10.1161/CIRCRESAHA.111.300388. View

19.

Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buleon M . Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab. 2008; 8(5):437-45. DOI: 10.1016/j.cmet.2008.10.003. View

20.

Petersen M, Shulman G . Mechanisms of Insulin Action and Insulin Resistance. Physiol Rev. 2018; 98(4):2133-2223. PMC: 6170977. DOI: 10.1152/physrev.00063.2017. View